SK pharmteco today announced details of its ongoing strategic manufacturing partnership with Genethon, a France-based pioneering nonprofit research and development organization dedicated to gene ...
Explore how analytical ultracentrifugation supports viral vector characterization and how it compares with complementary ...
Viral vector service expansion empowers scientists by offering high-quality research reagents through on-demand AAV production from Addgene’s vast plasmid repository WATERTOWN, Mass.--(BUSINESS WIRE)- ...
Viral vectors are engineered viruses that are used to deliver genetic material into cells for various applications, such as gene therapy, vaccine development, and biotechnology research. These viruses ...
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its reference materials for adeno associated virus (AAV) and lentiviral ...
The field of cell and gene therapy (CGT) has made remarkable strides in recent years, offering new hope to patients across an increasingly wide range of conditions. However, the field’s growth has ...
SK pharmteco today announced the launch of SKyvec, its proprietary, multimodal viral vector platform. Designed to support gene therapy programs ...
Less than two months after OXB revealed an equity raise of 60 million pounds sterling ($81 million) as part a plan to expand its operations in the U.S., the U.K.-based cell and gene therapy ...
Scientists have successfully edited the genome of biting midges, opening the door to new research on how these insects ...
Viral vector release testing requires a battery of analytical methods that, for the most part, did not exist a decade ago, and the regulatory bar rises with every new gene therapy approval. For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results